SpoonfulONE is a revolutionary, science-backed line of nutritional products that makes food allergen introduction & maintenance easy and safe. Each serving of pediatrician recommended SpoonfulONE includes the food groups commonly associated with over 90% of food allergies. SpoonfulONE was invented by Before Brands and globally renowned pediatric allergist, Dr. Kari Nadeau, who also directs the Sean N. Parker Center for Allergy and Asthma Research at Stanford University's School of Medicine. The company headquarters in Menlo Park, CA, and has been backed since inception by Gurnet Point Capital along with a consortium of families from the food allergy community. In 2019, a global partnership was formed with Nestlé Health Science in which Nestlé acquired the non-U.S. rights to commercialize SpoonfulONE around the world.
JUNE 22, 2022 | INTENT Infant Feeding Clinical Trial Proves that Digital Methods are the Future for Participant Recruitment Efforts |Link
JULY 19, 2021 | SpoonfulONE Announces Nationwide Launch In Target, Making Multi-Allergen Feeding More Accessible |Link
APRIL 13, 2021 | SpoonfulONE Launches Feeding Revolution To Bring Early Allergen Introduction To 1M+ Babies By 2030 |Link
OCTOBER 6, 2020 | SpoonfulOne to Launch Digital Food Allergy Prevention Trial with Duke Clinical Research Institute |Link
DECEMBER 10, 2019 | Gregory Shewchuk Named CEO of Before Brands, a Specialist in Early Childhood Food Allergy Prevention |Link
SEPTEMBER 26, 2019 | Nestlé Health Science invests in BEFORE Brands™ |Link
MARCH 20, 2017 | BEFORE Brands™, Inc. Secures $35 Million in Series B Funding Led by Gurnet Point Capital |Link
OCTOBER 5, 2016 | BEFORE Brands™, Inc. Closes $13.1M Series A Financing |Link